MYD88 and Alzheimer disease: Thus, MyD88, IRAK4, and TRAF6 play major roles in the initiation and progression of AD, and our findings demonstrated the lower expression of MyD88, IRAK4, and TRAF6 with TMTH treatment in DNCB-treated AD mice (Figure 4A).